Search Result "EP2302"
EP2300 Compounds: Focusing on the Antiatherosclerotic Properties of Squalene Synthase Inhibitors
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3167-3178
Author(s): A. Tavridou, V. G. Manolopoulos
Editorial [Hot Topic: Drugs Targeting Atherosclerosis: Current and Emerging Approaches (Executive Editors: Vangelis G. Manolopoulos and Anna Tavridou)]
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3091-3093
Author(s): Vangelis G. Manolopoulos, Anna Tavridou
Emerging Targets for the Treatment of Dyslipidemia
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2011 Page: 909-922
Author(s): A. Tavridou, G. Ragia, V. G. Manolopoulos
Medicinal Chemistry of 2,2,4-Substituted Morpholines
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 3422-3430
Author(s): E. A. Rekka, P. N. Kourounakis
Novel Molecules Targeting Dyslipidemia and Atherosclerosis
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 8 Year: 2008 Page: 792-802
Author(s): A. Tavridou, V. G. Manolopoulos
Multi-Target Drug Design Approaches for Multifactorial Diseases: From Neurodegenerative to Cardiovascular Applications
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 24 Year: 2014 Page: 2743-2787
Author(s): M.G. Katselou,A.N. Matralis,A.P. Kourounakis
The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 5 Year: 2009 Page: 526-542
Author(s): Andrew J. Wiemer, Raymond J. Hohl, David F. Wiemer